REFERENCES
1. Li B, Le C, Lei W, et al. STRaM: a genetic framework for improved cell product provenance for research and clinical translations. Commun Biol. 2025;8:1232.
3. Ben-David U, Siranosian B, Ha G, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560:325-30.
4. Lin YC, Boone M, Meuris L, et al. Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations. Nat Commun. 2014;5:4767.
5. Žymantaitė E, Gabrielaite M, Pašukonienė V, Mlynska A. Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains. Dis Model Mech. 2025;18:dmm052451.
6. Bian X, Yang Z, Feng H, Sun H, Liu Y. A combination of species identification and STR profiling identifies cross-contaminated cells from 482 human tumor cell lines. Sci Rep. 2017;7:9774.
7. Freedman LP, Gibson MC, Ethier SP, Soule HR, Neve RM, Reid YA. Reproducibility: changing the policies and culture of cell line authentication. Nat Methods. 2015;12:493-7.
8. Weiskirchen S, Schröder SK, Buhl EM, Weiskirchen R. A Beginner’s guide to cell culture: practical advice for preventing needless problems. Cells. 2023;12:682.
9. Almeida JL, Cole KD, Plant AL. Standards for cell line authentication and beyond. PLoS Biol. 2016;14:e1002476.
10. Chen A, Chen J, Xuan Y, Zhao J, Ji C, Zhang S. Innovative use of forensic STRs for authentication of human cell lines stored over 34 years. J Transl Genet Genom. 2025;9:149-66.
11. Chen YH, Connelly JP, Florian C, Cui X, Pruett-Miller SM. Short tandem repeat profiling via next-generation sequencing for cell line authentication. Dis Model Mech. 2023:16.
12. Ren Z, Zhang J, Zhang Y, et al. NASTRA: accurate analysis of short tandem repeat markers by nanopore sequencing with repeat-structure-aware algorithm. Brief Bioinform. 2024:25.
13. Chialastri A, Flowers K, Cogburn LA, Fink D, Dashnau JL. Cell line authentication using optical genome mapping. BMC Genomics. 2025;26:666.






